Login to Your Account



Polyphor's Protein Mimetics in $68M Allergan Deal

By Cormac Sheridan


Wednesday, November 5, 2008
Polyphor AG secured its first licensing deal with its proprietary Protein Epitope Mimetic (PEM) technology, an alliance in ophthalmology with Allergan Inc., worth up to $68 million. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription